GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Price-to-Free-Cash-Flow

InhaleRx (ASX:IRX) Price-to-Free-Cash-Flow : N/A (As of May. 28, 2024)


View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Price-to-Free-Cash-Flow?

As of today (2024-05-28), InhaleRx's share price is A$0.03. InhaleRx's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was A$-0.01. Hence, InhaleRx's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for InhaleRx's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:IRX's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 33.42
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

InhaleRx's Free Cash Flow per Share for the six months ended in Jun. 2023 was A$-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was A$-0.01.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 3.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 20.30% per year.

During the past 7 years, InhaleRx's highest 3-Year average Free Cash Flow per Share Growth Rate was 37.00% per year. The lowest was 3.10% per year. And the median was 27.15% per year.


InhaleRx Price-to-Free-Cash-Flow Historical Data

The historical data trend for InhaleRx's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Price-to-Free-Cash-Flow Chart

InhaleRx Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

InhaleRx Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of InhaleRx's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, InhaleRx's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InhaleRx's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InhaleRx's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where InhaleRx's Price-to-Free-Cash-Flow falls into.



InhaleRx Price-to-Free-Cash-Flow Calculation

InhaleRx's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.03/-0.011
=N/A

InhaleRx's Share Price of today is A$0.03.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. InhaleRx's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was A$-0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

InhaleRx  (ASX:IRX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


InhaleRx Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of InhaleRx's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


InhaleRx (ASX:IRX) Business Description

Traded in Other Exchanges
N/A
Address
126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000
InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx (ASX:IRX) Headlines

No Headlines